Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY METI Proposes “Bold Investment” Tax Breaks in FY2026 Request
September 1, 2025
-
REGULATORY Japan Panel Green Lights Nonprescription Switch of Morning-After Pill
September 1, 2025
-
REGULATORY MHLW Orders Label Revision for Elevidys to Add Acute Hepatic Failure
September 1, 2025
-
ORGANIZATION Indicators Needed to Frame Pharma as Growth Market in Japan, Says JPMA Policy Chief
August 29, 2025
-
REGULATORY Japan to Expand List of “Stable Supply Medicines” to 759 APIs, Adding Vaccines and Blood Products
August 28, 2025
-
COMMENTARY Pharmacies Reel from Pricey Drug Waste, Sparking Calls for Packaging Overhaul and Price Penalties
August 27, 2025
-
REGULATORY MHLW Pharma Bureau Seeks FY2026 Budget to Bolster PMDA and Speed Up SaMD Reviews
August 27, 2025
-
REGULATORY MHLW Seeks New R&D Tax Credit Scheme for Strategic Technologies in FY2026 Proposal
August 27, 2025
-
REGULATORY Japan Approves 3 New Drugs, Expands Label for Enhertu, Silgard 9 and More
August 26, 2025
-
BUSINESS Meiji Revives Penicillin Raw Material Production in Japan after 31 Years, Races to Pass Down Know-How
August 26, 2025
-
BUSINESS Astellas CFO Outlines Cost Cuts, Licensing Push as Xtandi Nears Patent Cliff
August 25, 2025
-
REGULATORY Novartis’ Radioligand Therapy, More Meds Inch Closer to Japan Approval with Panel OK
August 25, 2025
-
REGULATORY PMDA’s “Early Considerations” Start to Pay Off with Faster Reviews
August 22, 2025
-
REGULATORY Japan Mulls Preferential R&D Tax Credits for Strategic Technologies in FY2026 Reform Talks
August 22, 2025
-
ORGANIZATION Hemp Cannabinoid Consortium Draws 40 Inquiries from Industry and Academia
August 22, 2025
-
BUSINESS Linepharma Japan Eyes Ophthalmology as Second Pillar to Women’s Health
August 22, 2025
-
REGULATORY AMED to Put Practicality First in Project Selection: Ecosystem Coordinator
August 21, 2025
-
BUSINESS Itochu Launches J-STEP to Help Overseas Drug Makers Tackle Japan’s “Drug Loss”
August 21, 2025
-
BUSINESS Alloy Japan Looks to Turn iCAR-T into Shared Infrastructure, IND Filing Slated for 2026
August 20, 2025
-
BUSINESS Keytruda Retains Top Spot in Japan Drug Market in April-June: IQVIA
August 20, 2025
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…